Head-to-head · Value Score
Alan Meds vs Invyncible
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Invyncible a 68. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameInvyncible
#279 · Grade C · Watch List
Est. first month
From $192/mo (starting dose, compounded)
Save ~86% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 68 — an est. $99/mo first month, with no teaser step-up baked in. Invyncible isn't out of it: Shoppers who want corporate-parent-disclosed Florida GLP-1 platform with LegitScript seal.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | Invyncible |
|---|---|---|
| Value Score | 90 (A) | 68 (C) |
| Est. first month | $99/mo | From $192/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~86% |
| Semaglutide | $99/mo | From $192/mo (starting dose, compounded) |
| Tirzepatide | $145/mo | From $210/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 40 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Invyncible
Invyncible is a Florida-based telehealth platform offering semaglutide and tirzepatide programs for weight management.
Why it's a deal
- Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
- Physical corporate address published (St. Petersburg, FL)
- LegitScript verification seal displayed
- No long-term commitment required
- Offers both semaglutide and tirzepatide programs
The fine print
- Pricing not disclosed on the public site — fully gated behind signup
- Drug forms (compounded vs brand, injection vs oral) not disclosed
- 503A vs 503B designation not specified
- Pharmacy partner not named
- States served not listed publicly
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Invyncible.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.